<p>Marc-Andre Langlois of the University of Ottawa in Canada will develop small molecules that combine together to form a toxic compound only when they enter an HIV-infected cell. Because the molecules are non-toxic for healthy cells, they could constitute promising candidates for a vaccine-based delivery system aimed at specifically eliminating HIV-infected cells.</p>


Marc-Andre Langlois of the University of Ottawa in Canada will develop small molecules that combine together to form a toxic compound only when they enter an HIV-infected cell. Because the molecules are non-toxic for healthy cells, they could constitute promising candidates for a vaccine-based delivery system aimed at specifically eliminating HIV-infected cells.